Table 1.
Peptide | Flexible regions (solvent-exposed) | β-structured regions (non-exposed) | Method | References |
---|---|---|---|---|
Aβ1−40 |
N-terminus (Asp1-Phe19) C-terminus (Met35-Val40) |
Phe20-Leu34 | HDX-MS coupled with online proteolysis | [191] |
Aβ1−40 |
N-terminus (Asp1-His14) C-terminus (Gly37-Val39) Turn? (Ser26-Asn27) |
Gln15-Asp23 Lys28-Met35 |
HDX-solution NMR | [52] |
Aβ1−40 |
N-terminus (Asp1-His14) C-terminus (Gly37-Val40) Turns (Glu22-Asp23, Gly29-Ala30) |
Gln15-Ala21 Val24-Lys28 Ile31-Val36 |
Scanning proline mutagenesis | [58] |
Aβ1−40 |
N-terminus (Asp1-Tyr10) Bend (Gly25-Gly29) |
Val12-Val24 C-terminus (Ala30-Val40) |
Solid-state NMR | [50] |
Aβ1−40 |
N-terminus (Asp1-Gly9) Bend/loop (Asp23-Gly29) |
Tyr10-Glu22 C-terminus (Ala30-Val40) |
Solid-state NMR | [59] |
Aβ1−40 Aβ1−42 |
N-terminus (Asp1-Tyr10) C-terminus (Val40-Ala42?) Turn/bend? (Asp23-Gly29) |
His14-Gly38 | Site-directed spin labeling-EPR | [44] |
Aβ1−42 |
N-terminus (Asp1-Leu17) Turn (Asn27-Ala30) |
Val18-Ser26 C-terminus (Ile31-Ala42) |
HDX-solution NMR | [53] |
Aβ1−42 |
N-terminus (Asp1-Tyr10) Bend region? (Ser26-Asn27) |
Glu11-Gly25 C-terminus (Lys28-Ala42) |
HDX-solution NMR | [54] |
Fibril structures deposited in the PDB: synthetic Aβ1−40 (2LMN, 2LMO, 2LMP, 2LMQ), brain-derived Aβ1−40 (2M4J), synthetic D23N Aβ1−40 (2LNQ), recombinant Aβ1−42 (2BEG)